CVR Medical Corp. CRRVF
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 437.73% | 458.74% | -- | -- | -- |
| Depreciation & Amortization | -75.00% | -50.00% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 514.17% | 557.68% | -- | -- | -- |
| Operating Income | -514.17% | -557.68% | -- | -- | -- |
| Income Before Tax | -606.66% | -709.73% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -606.66% | -709.73% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -606.66% | -709.73% | -- | -- | -- |
| EBIT | -514.17% | -557.68% | -- | -- | -- |
| EBITDA | -513.43% | -556.53% | -- | -- | -- |
| EPS Basic | -589.74% | -696.88% | -- | -- | -- |
| Normalized Basic EPS | -265.52% | -300.00% | -- | -- | -- |
| EPS Diluted | -589.74% | -696.88% | -- | -- | -- |
| Normalized Diluted EPS | -265.52% | -300.00% | -- | -- | -- |
| Average Basic Shares Outstanding | 3.72% | 2.28% | -- | -- | -- |
| Average Diluted Shares Outstanding | 3.72% | 2.28% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |